CoreCap Advisors, LLC

SEC CIK: 0001902501
Latest filing: Jul 6, 2026

SEC filings (opens in a new tab)

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by CoreCap Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overview All 13F holders of ACAD Full Q2 2026 holdings

Shares (Q2 2026): 4
Value: $101
% of portfolio: <0.1%
Quarters held: 3; Since Q3 2025

Holdings of ACAD by CoreCap Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	4	$101	<0.1%	+4	New	Holders
Q1 2026	0	$0	0.0%	−15,366−100.0%	Sold out	Holders
Q4 2025	15,366	$410.4K	<0.1%	−2,956−16.1%	Reduced	Holders
Q3 2025	18,322	$391.0K	<0.1%	+18,322	New	Holders